1 Riemann D, Nissen C, Palagini L, Otte A, Perlis ML, Spiegelhalder K. The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol. 2015;14:547–58.
2 Leger D, Partinen M, Hirshkowitz M, Chokroverty S, Hedner J, Investigators ES. Characteristics of insomnia in a primary care setting: EQUINOX survey of 5293 insomniacs from 10 countries. Sleep Med. 2010;11:987–98.
3 https://www.bfs.admin.ch/bfs/fr/home/statistiques/catalogues-banques-donnees/publications.assetdetail.350824.html.
4 Bassetti CL, Ferini-Strambi L, Brown S, et al. Neurology and psychiatry: waking up to opportunities of sleep. State of the art and clinical/research priorities for the next decade. Eur J Neurol. 2015;22:1337–54.
5 Wilt TJ, MacDonald R, Brasure M, et al. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice. Guideline by the American College of Physicians. Ann Intern Med. 2016;165:103–12.
6 Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017.
7 FRD Drug Safety Communication, 11. 12. 2017. FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR.
https://www.fda.gov/Drugs/DrugSafety/ucm352085.htm.
8 Farkas RH, et al. Zolpidem and driving Impairment – identifying persons at risk. N Engl J Med. 2013;369:689–91.
– Trauer JM, Cunnington D. Cognitive Behavioral Therapy for Chronic Insomnia. Ann Intern Med. 2016;164(2):134–5.
doi:10.7326/L15-0484.
– Zachariae R, Lyby MS, Ritterband LM, O’Toole MS. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia – A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2016;30:1–10.
doi:10.1016/j.smrv.2015.10.004.
– Hintze JP, Edinger JD. Hypnotic Discontinuation in Chronic Insomnia. Sleep Med Clin. 2018;13:263–70.